Board of Directors of the Company interalia approved the un-audited financial results for the quarter ended 30.06.2025 at their Board Meeting held on 30.07.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sunil Healthcare Limited's Board approved unaudited standalone and consolidated financial results for Q1 FY26 ended June 30, 2025. Standalone revenue from operations stood at around Rs. 9.43 crore versus Rs. 10.25 crore in Q1 FY25, indicating a single-digit decline. The company swung to a standalone profit before tax of about Rs. 21 lakh from a loss of Rs. 75 lakh in the year-ago quarter. Consolidated revenue rose to about Rs. 22.54 crore from Rs. 21.50 crore, with consolidated PAT improving to roughly Rs. 16 lakh. Auditor Singhi & Co. issued an unqualified review report with no qualifications or emphasis of matter. The Board also fixed the 51st AGM for September 29, 2025 via video conferencing, with book closure from September 23 to 29, 2025.
A modest top-line dip on a standalone basis but a turnaround from loss to profit suggests margin recovery rather than growth. For shareholders, this is mildly positive on profitability, but the weak revenue print and small absolute earnings keep it neutral for the stock in the near term.